Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Burning Rock Biotech (BNR) Intangibles (2019 - 2025)

Burning Rock Biotech has reported Intangibles over the past 7 years, most recently at $40041.9 for Q4 2025.

  • For Q4 2025, Intangibles fell 31.68% year-over-year to $40041.9; the TTM value through Dec 2025 reached $40041.9, down 31.68%, while the annual FY2025 figure was $41000.0, 29.31% down from the prior year.
  • Intangibles for Q4 2025 was $40041.9 at Burning Rock Biotech, down from $44000.0 in the prior quarter.
  • Over five years, Intangibles peaked at $805509.4 in Q4 2021 and troughed at $40041.9 in Q4 2025.
  • A 5-year average of $290864.4 and a median of $170500.0 in 2023 define the central range for Intangibles.
  • Biggest five-year swings in Intangibles: soared 2123.53% in 2021 and later tumbled 66.8% in 2023.
  • Year by year, Intangibles stood at $805509.4 in 2021, then plummeted by 65.33% to $279239.7 in 2022, then crashed by 52.05% to $133887.4 in 2023, then crashed by 56.22% to $58609.8 in 2024, then tumbled by 31.68% to $40041.9 in 2025.
  • Business Quant data shows Intangibles for BNR at $40041.9 in Q4 2025, $44000.0 in Q3 2025, and $49000.0 in Q2 2025.